Tenax Therapeutics Financial Statements 2009-2025 | TENX

Revenue

$0.049

Cost Of Goods Sold

Gross Profit

$0.049

Research And Development Expenses

$3.229

$5.377

$25.147

$4.561

$3.471

$1.239

$3.527

$13.14

$6.66

SG&A Expenses

$5.005

$5.675

$7.581

$5.307

$5.084

$5.654

$5.679

$6.246

$7.171

Other Operating Income Or Expenses

$-33.265

$-1.035

Operating Expenses

Operating Income

$-8.234

$-11.053

$-32.729

$-9.868

$-8.555

$-6.893

$-9.206

$-52.651

$-14.817

Total Non-Operating Income/Expense

$0.523

$0.005

$0.255

$0.017

$0.161

$0.08

$0.366

$8.727

$0.735

Pre-Tax Income

$-7.711

$-11.048

$-32.474

$-9.851

$-8.394

$-6.813

$-8.84

$-43.924

$-14.082

Income Taxes

Income After Taxes

$-7.711

$-11.048

$-32.474

$-9.851

$-8.394

$-6.813

$-8.84

$-43.924

$-14.082

Other Income

Income From Continuous Operations

$-7.711

$-11.048

$-32.474

$-9.851

$-8.394

$-6.813

$-8.84

$-43.924

$-14.082

Income From Discontinued Operations

Net Income

$-7.711

$-11.048

$-32.474

$-9.851

$-8.394

$-14.144

$-8.84

$-43.924

$-14.082

EBITDA

$-8.226

$-10.939

$-32.61

$-9.746

$-8.449

$-6.793

$-9.005

$-51.979

$-13.994

EBIT

$-8.234

$-11.053

$-32.728

$-9.868

$-8.555

$-6.893

$-9.206

$-52.651

$-14.817

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-31.04

$-600.71

$-2524.80

$-1520.00

$-2160.00

$-14464.00

$-10032.00

$-49984.00

$-16000.00

EPS - Earnings Per Share

$-31.04

$-600.71

$-2524.80

$-1520.00

$-2160.00

$-14464.00

$-10032.00

$-49984.00

$-16000.00